Boston Scientific Corporation (NYSE: BSX) welcomed the publication of an article in the current edition of the Journal of American College of Cardiology (JACC) reviewing data on more than 19,000 patients from the Swedish national registry who were evaluated for restenosis, or the re-narrowing of arteries after percutaneous coronary intervention (PCI). Read more ...
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment